speb/financial-data huggingface dataset:
Financial ratios for HRTX — quarterly report dated 2025-12-31
Total revenue: 40588000
Gross profit: 29469000
Operating income: 38000
Net income: -2954000
Capital expenditures: 16000
Operating cash flow: -9184000
Depreciation & amortization: 537000
Net tangible assets: 14333000
Owner earnings: -2433000
Return on net tangible assets (%): -16.974813367752738
Capex to operating income (%): 42.10526315789473
Buffett classification: The Good
Stock price: 1.3
Shares outstanding: 189279369
Book value: 14333000
P/B ratio: 17.1675978301821
Market cap (USD): 246063179.70000002
Debt to equity: 9.81218167864369
Current ratio: 2.4773252304938707
Quick ratio: 1.512206289412891
COGS to revenue (%): 27.394796491573864
R&D to revenue (%): 9.229328865674583
SG&A to revenue (%): 63.28225091159949
Free cash flow (dilution-adjusted): -11363000
Buyback yield (%): 0
Retained earnings: -1939789000
Inventory turnover: 0.1198865719276303
Receivables turnover: 0.45305680511681384
Capitalized R&D asset: 7039120
ROCI (R&D-adjusted, %): 0.24018174204736664
Rosenberg metric: 0.9135446685878963
FCF margin (%): -27.99595939686607
Revenue growth (%): 6.215162379295005
Rule of 40 score: -21.780797017571064
Financial ratios for HRTX — annual report dated 2025-12-31
Total revenue: 154904000
Gross profit: 113557000
Operating income: -2538000
Net income: -20195000
Capital expenditures: 219000
Operating cash flow: -27591000
Depreciation & amortization: 2314000
Net tangible assets: 14333000
Owner earnings: -18100000
Return on net tangible assets (%): -126.28200655829205
Buffett classification: The Gruesome
Stock price: 1.3
Shares outstanding: 189279369
Book value: 14333000
P/B ratio: 17.1675978301821
Market cap (USD): 246063179.70000002
Debt to equity: 9.81218167864369
Current ratio: 2.4773252304938707
Quick ratio: 1.512206289412891
Interest coverage ratio: -0.2642373763664758
COGS to revenue (%): 26.69201570004648
R&D to revenue (%): 8.023679181944948
SG&A to revenue (%): 66.92273924495171
Free cash flow (dilution-adjusted): -38247000
Buyback yield (%): 0
Retained earnings: -1939789000
Inventory turnover: 0.44580898367584587
Receivables turnover: 1.7290901581702702
Capitalized R&D asset: 36520500
ROCI (R&D-adjusted, %): -6.54985536556809
Rosenberg metric: 0.47473475993526343
FCF margin (%): -24.690776222692765
Revenue growth (%): 7.359739404650519
Rule of 40 score: -17.331036818042246
Financial ratios for HTCR — annual report dated 2022-12-31
Total revenue: 66343.00331026182
Gross profit: 25212.87240445381
Operating income: -50376.760457418
Net income: -50236.72885946435
Capital expenditures: 429.36352693349386
Operating cash flow: -36176.24887150166
Depreciation & amortization: 626.9410171531749
Net tangible assets: 36169.34246163106
Owner earnings: -50039.15136924466
Return on net tangible assets (%): -138.3468649515177
Buffett classification: The Gruesome
Stock price: 14.73
Shares outstanding: 1441565
Book value: 36169.342461631066
P/B ratio: 587.0787524690444
Market cap (USD): 21234252.45
Debt to equity: 0.9473031300876169
Current ratio: 2.3398726263421836
Quick ratio: 2.3398726263421836
Interest coverage ratio: -160.19327751196172
COGS to revenue (%): 61.996184757354925
R&D to revenue (%): 7.269248355013976
SG&A to revenue (%): 105.7960412378242
Free cash flow (dilution-adjusted): -48039.128799277765
Buyback yield (%): 0.12400543936711807
Retained earnings: -79548.44267228409
Receivables turnover: 14.709174644001527
Capitalized R&D asset: 4822.637676798075
ROCI (R&D-adjusted, %): -68.64634162366731
FCF margin (%): -72.41024132509713
Rule of 40 score: -72.41024132509713
Financial ratios for HTCR — annual report dated 2023-12-31
Total revenue: 154463.904405006
Gross profit: 57041.745032878454
Operating income: -28584.762780173936
Net income: -29625.185604185815
Capital expenditures: 3545.5419642225834
Operating cash flow: -30624.400763628648
Depreciation & amortization: 4829.378491126352
Net tangible assets: -18572.933606731243
Owner earnings: -28341.349077282044
Buffett classification: The Gruesome
Stock price: 10.33
Shares outstanding: 1441565
Book value: 54209.248391430374
P/B ratio: 274.7015849117379
Market cap (USD): 14891366.45
Debt to equity: 0.6383343850522526
Current ratio: 0.8438680161651095
Quick ratio: 0.8438680161651095
Interest coverage ratio: -24.80697437533749
COGS to revenue (%): 63.07114904766723
R&D to revenue (%): 4.665151198192058
SG&A to revenue (%): 48.068244603203446
Free cash flow (dilution-adjusted): -44460.02969666973
Buyback yield (%): 0
Retained earnings: -104387.11023120978
Receivables turnover: 7.89102527054948
Capitalized R&D asset: 10437.141930579082
ROCI (R&D-adjusted, %): -24.61329818700101
Rosenberg metric: 6.599888849530367
FCF margin (%): -28.783442881318766
Revenue growth (%): 132.82621632704078
Rule of 40 score: 104.04277344572202
Financial ratios for HTCR — quarterly report dated 2024-09-30
Capital expenditures: 246.59616192744082
Depreciation & amortization: 191.46939347247513
Buffett classification: The Gruesome
Stock price: 14.47
Shares outstanding: 1441565
Market cap (USD): 20859445.55
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HTCR — annual report dated 2024-12-31
Total revenue: 144503.11484807948
Gross profit: 93736.19975794636
Operating income: 44543.314860819155
Net income: -9436.104210459265
Capital expenditures: 47.4297725969807
Operating cash flow: -24780.667558443212
Depreciation & amortization: 4306.306134148672
Net tangible assets: 29641.996305497163
Owner earnings: -5177.227848907574
Return on net tangible assets (%): -17.465854173753634
Capex to operating income (%): 0.10648011434528531
Buffett classification: The Great
Stock price: 30.9
Shares outstanding: 1441565
Book value: 22052.455570418504
P/B ratio: 2019.927366263577
Market cap (USD): 44544358.5
Debt to equity: 0.30187535293752327
Current ratio: 1.2688921789309813
Quick ratio: 1.2688921789309813
Interest coverage ratio: 58.86786655330038
COGS to revenue (%): 35.13205590308965
R&D to revenue (%): 0.7924077112719888
SG&A to revenue (%): 30.289822452571563
Free cash flow (dilution-adjusted): -27129.505064016816
Buyback yield (%): 0
Retained earnings: -103476.92846678132
Receivables turnover: 20.071386418672798
Capitalized R&D asset: 7564.527298801095
ROCI (R&D-adjusted, %): 83.86173155465164
Rosenberg metric: 5.092226425751053
FCF margin (%): -18.774339288491387
Revenue growth (%): -6.448619562800399
Rule of 40 score: -25.222958851291786
Financial ratios for HTCR — quarterly report dated 2024-12-31
Capital expenditures: 21.096885151920503
Buffett classification: The Gruesome
Stock price: 30.9
Shares outstanding: 1441565
Market cap (USD): 44544358.5
Buyback yield (%): 0
Capitalized R&D asset: 2685.8589719090387
Rule of 40 score: 0
Financial ratios for HTCR — quarterly report dated 2025-03-31
Total revenue: 13991.531880764604
Gross profit: 3634.3670632268413
Operating income: -7955.84146504478
Net income: -20632.21494452613
Capital expenditures: 0
Operating cash flow: -11305.032749632403
Depreciation & amortization: 135.6035289399813
Net tangible assets: 12303.976741077397
Owner earnings: -20496.61141558615
Return on net tangible assets (%): -166.58525813981154
Buffett classification: The Gruesome
Stock price: 12.77
Shares outstanding: 1441565
Book value: 4012.0772623980665
P/B ratio: 4588.342608087474
Market cap (USD): 18408785.05
Debt to equity: 6.349309580250794
Current ratio: 0.9057585570472053
Quick ratio: 0.9057585570472053
Interest coverage ratio: -66.8963133640553
COGS to revenue (%): 74.0245235889908
R&D to revenue (%): 5.91823018200422
SG&A to revenue (%): 82.83730921705369
Free cash flow (dilution-adjusted): -11520.779307579201
Buyback yield (%): 0
Retained earnings: -129206.2224301564
Receivables turnover: 0.9274757787398742
Capitalized R&D asset: 2627.57657387121
ROCI (R&D-adjusted, %): -31.669224878118296
FCF margin (%): -82.34108606376287
Rule of 40 score: -82.34108606376287
Financial ratios for HTCR — quarterly report dated 2025-06-30
Total revenue: 32827.608635482975
Gross profit: 15344.554386936063
Operating income: 743.5995017990589
Net income: 7610.725159147522
Capital expenditures: 8.545530030445612
Operating cash flow: -6804.822861887627
Depreciation & amortization: 153.25214503182949
Net tangible assets: 33493.17741489067
Owner earnings: 7755.431774148906
Return on net tangible assets (%): 23.155258392119382
Capex to operating income (%): 1.1492113711440934
Buffett classification: The Great
Stock price: 8.34
P/E ratio: 394.9246572631016
Shares outstanding: 1441565
Book value: 24626.466924993074
P/B ratio: 488.20044453061064
Market cap (USD): 12022652.1
Debt to equity: 1.0133812229612842
Current ratio: 1.2584489476929428
Quick ratio: 1.2584489476929428
Effective tax rate (%): -0.336690788926446
Interest coverage ratio: 3.2899127506505432
COGS to revenue (%): 53.25716668149164
R&D to revenue (%): 3.4037231627533644
SG&A to revenue (%): 41.07394515377153
Free cash flow (dilution-adjusted): -7006.587323553833
Buyback yield (%): 0
Retained earnings: -126155.08580127318
Receivables turnover: 1.5087513535602808
Capitalized R&D asset: 2558.4885916376834
ROCI (R&D-adjusted, %): 0.6740286007277423
Rosenberg metric: 14.141866185929583
FCF margin (%): -21.343581256115304
Revenue growth (%): 134.62483533067592
Rule of 40 score: 113.28125407456062
Financial ratios for HTCR — quarterly report dated 2025-09-30
Total revenue: 20123.34454912517
Gross profit: 9881.621803499327
Operating income: -75.0134589502019
Net income: 2921.076716016151
Capital expenditures: 0
Operating cash flow: -2059.663526244953
Depreciation & amortization: -36.628532974428
Net tangible assets: 34935.75370121131
Owner earnings: 2884.448183041723
Return on net tangible assets (%): 8.25643610757913
Buffett classification: The Gruesome
Stock price: 13.79
P/E ratio: 1701.357348901795
Shares outstanding: 1441565
Book value: 25737.671601615075
P/B ratio: 772.3768357022844
Market cap (USD): 19879181.349999998
Debt to equity: 0.1878381056617942
Current ratio: 1.4005575732404822
Quick ratio: 1.4005575732404822
Interest coverage ratio: -0.5287198216572595
COGS to revenue (%): 50.89473432521974
R&D to revenue (%): 0
SG&A to revenue (%): 49.47803402234335
Free cash flow (dilution-adjusted): -2112.0390309555855
Buyback yield (%): 0
Retained earnings: -119770.26244952893
Receivables turnover: 2.2876061343939313
Capitalized R&D asset: 1021.8886663540624
ROCI (R&D-adjusted, %): -2.397668393218329
Rosenberg metric: -4.889138765292989
FCF margin (%): -10.495467221165296
Revenue growth (%): -38.69993768789456
Rule of 40 score: -49.19540490905986
Financial ratios for HTCR — quarterly report dated 2025-12-31
Total revenue: 12249.42778594719
Gross profit: 3531.6731666773226
Operating income: -7133.81497346717
Net income: 46972.07339684163
Capital expenditures: 0
Operating cash flow: -870.4238859407966
Depreciation & amortization: 59.96419666261748
Net tangible assets: 56135.30464804041
Owner earnings: 47032.03759350425
Return on net tangible assets (%): 83.78334790981856
Buffett classification: The Gruesome
Stock price: 6.1
P/E ratio: 238.49065710356618
Shares outstanding: 1441565
Book value: 46562.566332075956
P/B ratio: 188.85442089437225
Market cap (USD): 8793546.5
Debt to equity: 0.10383007973113827
Current ratio: 1.5788925472538813
Quick ratio: 1.5788925472538813
Interest coverage ratio: -53.08277830637488
COGS to revenue (%): 71.16866821543343
R&D to revenue (%): 0
SG&A to revenue (%): 90.12251472259207
Free cash flow (dilution-adjusted): 538.4438335144813
Buyback yield (%): 0
Retained earnings: -87945.36154977304
Receivables turnover: 0.9127128288751277
Capitalized R&D asset: 368.7291032383061
ROCI (R&D-adjusted, %): -15.07344408041049
FCF margin (%): 4.395665192885138
Revenue growth (%): -39.128270869467805
Rule of 40 score: -34.732605676582665
Financial ratios for HTCR — annual report dated 2025-12-31
Total revenue: 57341.1674445368
Gross profit: 20148.666965027813
Operating income: -19021.81446199092
Net income: 37042.9256441404
Capital expenditures: 0
Operating cash flow: -19929.039063998465
Depreciation & amortization: 296.4836007927882
Net tangible assets: 56135.30464804041
Owner earnings: 37339.40924493319
Return on net tangible assets (%): 66.51680164389496
Buffett classification: The Gruesome
Stock price: 6.1
P/E ratio: 237.38801261209233
Shares outstanding: 1441565
Book value: 46562.566332075956
P/B ratio: 188.85442089437225
Market cap (USD): 8793546.5
Debt to equity: 0.10383007973113827
Current ratio: 1.5788925472538813
Quick ratio: 1.5788925472538813
Interest coverage ratio: -33.94024640657084
COGS to revenue (%): 64.86177756231316
R&D to revenue (%): 0
SG&A to revenue (%): 67.79422107829735
Free cash flow (dilution-adjusted): -18962.738955309764
Buyback yield (%): 0
Retained earnings: -87945.36154977304
Receivables turnover: 4.27252766936155
Capitalized R&D asset: 3145.1577095575913
ROCI (R&D-adjusted, %): -41.47549514344392
Rosenberg metric: -64.26556654443256
FCF margin (%): -33.07002595238658
Revenue growth (%): -60.318386558780205
Rule of 40 score: -93.38841251116679
Financial ratios for IBS.LS — annual report dated 2021-12-31
Capital expenditures: 0
Net tangible assets: 129169973.86363636
Buffett classification: The Gruesome
Stock price: 4.590909090909091
Shares outstanding: 39837815
Market cap (USD): 182891787.04545453
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBS.LS — annual report dated 2022-12-31
Total revenue: 378294222.34042555
Gross profit: 183372967.0212766
Operating income: 23685201.063829787
Net income: 170079945.74468085
Capital expenditures: 42116870.21276596
Depreciation & amortization: 41555140.42553192
Net tangible assets: 321830554.2553192
Owner earnings: 169518215.9574468
Return on net tangible assets (%): 52.67312681037806
Capex to operating income (%): 177.81934845840763
Buffett classification: The Gruesome
Stock price: 4.680851063829788
P/E ratio: 1.0963954504273834
Shares outstanding: 39837815
Book value: 408184638.2978724
P/B ratio: 0.4568395310048988
Market cap (USD): 186474878.7234043
Debt to equity: 0.41948995703759007
Current ratio: 2.1422012775639203
Quick ratio: 2.0524133413714343
Effective tax rate (%): -14.716723855301941
Interest coverage ratio: 3.1362492277031233
COGS to revenue (%): 51.52636329289217
SG&A to revenue (%): 3.5308082514148214
Free cash flow (dilution-adjusted): 73559977.65957448
Buyback yield (%): 0.13104896805847774
Retained earnings: 348294773.40425533
Inventory turnover: 14.003674373302143
Receivables turnover: 24.008527633129955
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.392037803079357
FCF margin (%): 19.44517608661179
Rule of 40 score: 19.44517608661179
Financial ratios for IBS.LS — annual report dated 2023-12-31
Total revenue: 464649362.2222222
Gross profit: 223803028.8888889
Operating income: 27193456.666666664
Net income: 17263828.888888888
Capital expenditures: 33943602.222222224
Depreciation & amortization: 56372083.33333333
Net tangible assets: 304439928.8888889
Owner earnings: 39692309.999999985
Return on net tangible assets (%): 13.037813451364471
Capex to operating income (%): 124.82268303841559
Buffett classification: The Gruesome
Stock price: 6.044444444444444
P/E ratio: 13.948091185642737
Shares outstanding: 39837815
Book value: 394360098.88888884
P/B ratio: 0.6106030002376086
Market cap (USD): 240797459.55555555
Debt to equity: 0.7254002193128121
Current ratio: 1.598742702203831
Quick ratio: 1.5112107456906658
Effective tax rate (%): -9.161939911770563
Interest coverage ratio: 1.9501221510050963
COGS to revenue (%): 51.833996323909005
SG&A to revenue (%): 3.80139359852679
Free cash flow (dilution-adjusted): 43279095.55555555
Buyback yield (%): 1.4968817943453976
Retained earnings: 336816144.4444444
Inventory turnover: 16.43966241468048
Receivables turnover: 79.56636542452006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.356767193786525
FCF margin (%): 9.31435595834456
Revenue growth (%): 22.82750694619015
Rule of 40 score: 32.14186290453471
Financial ratios for IBS.LS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.022222222222222
Shares outstanding: 39837815
Market cap (USD): 279749989.7777778
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBS.LS — annual report dated 2024-12-31
Total revenue: 494063381.25
Gross profit: 235941438.5416667
Operating income: 25177778.125
Net income: 14428955.208333334
Capital expenditures: 40915396.875
Depreciation & amortization: 74966613.54166667
Net tangible assets: 253180097.9166667
Owner earnings: 48480171.875
Return on net tangible assets (%): 19.14849242650861
Capex to operating income (%): 162.50598711239536
Buffett classification: The Gruesome
Stock price: 6.802083333333334
P/E ratio: 18.780302075607953
Shares outstanding: 39837815
Book value: 356843801.0416667
P/B ratio: 0.7593802572915532
Market cap (USD): 270980137.4479167
Debt to equity: 0.929582075051751
Current ratio: 1.0594953534384632
Quick ratio: 0.9768188676172219
Effective tax rate (%): 6.5086496715337745
Interest coverage ratio: 1.5412259224368372
COGS to revenue (%): 52.244702300193666
SG&A to revenue (%): 4.206883071846766
Free cash flow (dilution-adjusted): 44139566.66666667
Buyback yield (%): 2.0108999997760635
Retained earnings: 301575618.75
Inventory turnover: 16.074795065018385
Receivables turnover: 58.560424360451044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.204874853678047
FCF margin (%): 8.933988703026687
Revenue growth (%): 6.330368966203445
Rule of 40 score: 15.264357669230133
Financial ratios for IBS.LS — quarterly report dated 2024-12-31
Operating income: 5682986.458333334
Net income: 1760925
Capital expenditures: 19636736.458333336
Net tangible assets: 253180097.9166667
Owner earnings: -17875811.458333336
Return on net tangible assets (%): -7.060512104003172
Capex to operating income (%): 345.5355138061029
Buffett classification: The Gruesome
Stock price: 6.802083333333334
P/E ratio: 38.47127751720214
Shares outstanding: 39837815
Market cap (USD): 270980137.4479167
Interest coverage ratio: 1.3666421761598067
Buyback yield (%): 0.3310159587517384
Inventory turnover: 4.014932334794709
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IBS.LS — quarterly report dated 2025-03-31
Total revenue: 125828690.2173913
Gross profit: 54813885.86956522
Operating income: -411236.95652173914
Net income: -3826397.8260869565
Capital expenditures: 12811898.913043479
Depreciation & amortization: 27311222.826086957
Net tangible assets: 258671102.17391303
Owner earnings: 10672926.086956521
Buffett classification: The Gruesome
Stock price: 8.304347826086955
Shares outstanding: 39837815
Book value: 366223525
P/B ratio: 0.9033474089118232
Market cap (USD): 330827072.3913043
Debt to equity: 0.9275223673016778
Current ratio: 1.0929380682941834
Quick ratio: 1.010391682745461
Interest coverage ratio: -0.08616570166066968
COGS to revenue (%): 56.43768859481526
Free cash flow (dilution-adjusted): 2336956.5217391304
Buyback yield (%): 0.5652273214775606
Retained earnings: 310861204.34782606
Inventory turnover: 4.664303017686103
Receivables turnover: 12.00902556699354
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.06684628861503593
FCF margin (%): 1.8572525214254596
Rule of 40 score: 1.8572525214254596
Financial ratios for IBS.LS — quarterly report dated 2025-06-30
Total revenue: 154070241.17647058
Gross profit: 71338123.52941176
Operating income: 8660314.11764706
Net income: 6024556.470588235
Capital expenditures: 21193624.70588235
Depreciation & amortization: 29649298.82352941
Net tangible assets: 248545978.82352942
Owner earnings: 14480230.588235293
Return on net tangible assets (%): 5.8259766087450675
Capex to operating income (%): 244.7212008476258
Buffett classification: The Gruesome
Stock price: 10.682352941176472
P/E ratio: 107.48992404501261
Shares outstanding: 39837815
Market cap (USD): 425561600.23529416
Quick ratio: -0.0918994428138891
Interest coverage ratio: 1.7106594549373428
COGS to revenue (%): 53.69766219311505
Free cash flow (dilution-adjusted): 50748116.47058824
Buyback yield (%): 0.6926108654359951
Retained earnings: 306731651.7647059
Inventory turnover: 4.405569254292204
Receivables turnover: 18.998616446142368
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3881353725836685
FCF margin (%): 32.93829884543494
Revenue growth (%): 22.444444832324812
Rule of 40 score: 55.382743677759755
Financial ratios for IBS.LS — quarterly report dated 2025-09-30
Total revenue: 174199775.29411766
Gross profit: 85715296.47058824
Operating income: 19606895.29411765
Net income: 11889970.588235294
Capital expenditures: 8617842.352941176
Depreciation & amortization: 30625918.82352941
Net tangible assets: 257921990.5882353
Owner earnings: 33898047.058823526
Return on net tangible assets (%): 13.142751799299168
Capex to operating income (%): 43.95312069385434
Buffett classification: The Good
Stock price: 11.03529411764706
P/E ratio: 27.738059260429736
Shares outstanding: 39837815
Book value: 373267632.9411765
P/B ratio: 1.1777662104410007
Market cap (USD): 439622005.52941185
Debt to equity: 0.9064312246445926
Current ratio: 1.0192354998529287
Quick ratio: 0.9178870727588928
Effective tax rate (%): 22.51840010345079
Interest coverage ratio: 4.060392569609659
COGS to revenue (%): 50.79482948478713
Free cash flow (dilution-adjusted): 42432170.5882353
Buyback yield (%): 0.7959923759605131
Retained earnings: 313794495.2941176
Inventory turnover: 4.411427428190215
Receivables turnover: 21.037789214918764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.1375270450177815
FCF margin (%): 24.358338302442196
Revenue growth (%): 13.065166877094004
Rule of 40 score: 37.4235051795362
Financial ratios for IBS.LS — annual report dated 2025-12-31
Total revenue: 622959943.5294118
Gross profit: 302862216.47058827
Operating income: 36268221.17647059
Net income: 17889943.529411767
Capital expenditures: 38799189.4117647
Depreciation & amortization: 120885624.70588236
Net tangible assets: 259653783.52941176
Owner earnings: 99976378.82352942
Return on net tangible assets (%): 38.50372502359659
Capex to operating income (%): 106.97847358705341
Buffett classification: The Gruesome
Stock price: 10.92941176470588
P/E ratio: 24.337912706395937
Shares outstanding: 39837815
Book value: 372904118.8235294
P/B ratio: 1.167602774983625
Market cap (USD): 435403883.9411764
Debt to equity: 0.9098547555676518
Current ratio: 1.062409877277237
Quick ratio: 0.9538605905121551
Effective tax rate (%): -2.5502182438076284
Interest coverage ratio: 1.81070182284906
COGS to revenue (%): 51.38335624683881
SG&A to revenue (%): 4.291957761453805
Free cash flow (dilution-adjusted): 106476820
Buyback yield (%): 2.89162623613101
Retained earnings: 317911423.5294118
Inventory turnover: 16.288067825795547
Receivables turnover: 80.30951248513675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.756784832850722
FCF margin (%): 17.092081297675428
Revenue growth (%): 26.089074230374727
Rule of 40 score: 43.181155528050155
Financial ratios for IBS.LS — quarterly report dated 2025-12-31
Total revenue: 158498874.11764705
Gross profit: 86480824.70588236
Operating income: 7401449.4117647065
Net income: 4124397.6470588236
Capital expenditures: 8987722.352941176
Depreciation & amortization: 31050024.705882356
Net tangible assets: 259653783.52941176
Owner earnings: 26186700
Return on net tangible assets (%): 10.085237212433592
Capex to operating income (%): 121.4319230319276
Buffett classification: The Gruesome
Stock price: 10.92941176470588
P/E ratio: 23.906835488281672
Shares outstanding: 39837815
Book value: 372904118.8235294
P/B ratio: 1.167602774983625
Market cap (USD): 435403883.9411764
Debt to equity: 0.9098547555676518
Current ratio: 1.062409877277237
Quick ratio: 0.9538605905121551
Effective tax rate (%): -30.051059813878737
Interest coverage ratio: 1.444186245637587
COGS to revenue (%): 45.43757790879243
Free cash flow (dilution-adjusted): 17311049.411764707
Buyback yield (%): 0.9461308775995766
Retained earnings: 317911423.5294118
Inventory turnover: 3.664614817101632
Receivables turnover: 20.43304299424883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.174817797306302
FCF margin (%): 10.921875318127146
Revenue growth (%): -9.01315811111772
Rule of 40 score: 1.9087172070094258
Financial ratios for IEI.V — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.0703125
Shares outstanding: 9451242
Market cap (USD): 29018266.453125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEI.V — annual report dated 2022-09-30
Total revenue: 13917586.861313868
Gross profit: 9823931.386861313
Operating income: 8636646.715328466
Net income: 5732606.569343065
Capital expenditures: 0
Operating cash flow: 8182532.846715328
Depreciation & amortization: 109518.24817518247
Net tangible assets: 77277981.02189781
Owner earnings: 5842124.817518247
Return on net tangible assets (%): 7.559882828541806
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.3868613138686126
P/E ratio: 5.583855356304078
Shares outstanding: 9451242
Book value: 77277981.0218978
P/B ratio: 0.41421949013833215
Market cap (USD): 32010045.897810213
Debt to equity: 1.232540276390002
Current ratio: 0.03564769827720251
Quick ratio: 0.03564769827720251
Effective tax rate (%): 19.893735925482346
Interest coverage ratio: 2.7613108623671994
COGS to revenue (%): 29.413543563586565
SG&A to revenue (%): 7.743917347866433
Free cash flow (dilution-adjusted): 8182532.846715328
Buyback yield (%): 0
Retained earnings: 72936852.55474453
Receivables turnover: 40.782610741556695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.593716716529002
FCF margin (%): 58.79275572879643
Rule of 40 score: 58.79275572879643
Financial ratios for IEI.V — annual report dated 2023-09-30
Total revenue: 14619825.925925925
Gross profit: 10092952.592592591
Operating income: 8907986.666666666
Net income: 5046614.814814814
Capital expenditures: 0
Operating cash flow: 8348692.592592592
Depreciation & amortization: 111141.48148148147
Net tangible assets: 82909381.48148148
Owner earnings: 5157756.296296296
Return on net tangible assets (%): 6.220956186301215
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.148148148148148
P/E ratio: 5.89581553017571
Shares outstanding: 9451242
Book value: 82909381.48148148
P/B ratio: 0.35887265672878993
Market cap (USD): 29753909.999999996
Debt to equity: 1.1756331645085243
Current ratio: 0.05684016687110056
Quick ratio: 0.05684016687110056
Effective tax rate (%): 20.48194992914149
Interest coverage ratio: 2.380070928428549
COGS to revenue (%): 30.963934565771034
SG&A to revenue (%): 7.344987894419373
Free cash flow (dilution-adjusted): 8348692.592592592
Buyback yield (%): 11.94967254661594
Retained earnings: 78503940
Receivables turnover: 11.771421056524012
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.76701619641622
FCF margin (%): 57.10528042462886
Revenue growth (%): 5.045695576465497
Rule of 40 score: 62.15097600109436
Financial ratios for IEI.V — annual report dated 2024-09-30
Total revenue: 14461408.888888888
Gross profit: 9649279.25925926
Operating income: 8127341.481481481
Net income: -3156313.333333333
Capital expenditures: 0
Operating cash flow: 7290911.111111111
Depreciation & amortization: 114392.59259259258
Net tangible assets: 79379365.18518518
Owner earnings: -3041920.7407407407
Return on net tangible assets (%): -3.8321303447617696
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.8666666666666667
Shares outstanding: 9451242
Book value: 79379365.18518518
P/B ratio: 0.34131742344868937
Market cap (USD): 27093560.4
Debt to equity: 1.0773641023584233
Current ratio: 0.09303077172224827
Quick ratio: 0.09303077172224827
Interest coverage ratio: 1.9640487729607794
COGS to revenue (%): 33.27566260384855
SG&A to revenue (%): 9.733112423552605
Free cash flow (dilution-adjusted): 7104540.740740741
Buyback yield (%): 15.978546094063875
Retained earnings: 74787553.33333333
Receivables turnover: 10.36109964176728
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.991585685631826
FCF margin (%): 49.127583593873496
Revenue growth (%): -1.0835767665065699
Rule of 40 score: 48.04400682736693
Financial ratios for IEI.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.8666666666666667
Shares outstanding: 9451242
Market cap (USD): 27093560.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEI.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.3916083916083917
Shares outstanding: 9451242
Market cap (USD): 22603669.67832168
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEI.V — quarterly report dated 2025-03-31
Total revenue: 3430813.986013986
Gross profit: 2354772.7272727275
Operating income: 1905044.7552447554
Net income: 1360969.9300699302
Capital expenditures: 0
Operating cash flow: 2432427.272727273
Depreciation & amortization: 31088.11188811189
Net tangible assets: 76823560.13986014
Owner earnings: 1392058.041958042
Return on net tangible assets (%): 1.8120196973737595
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.412587412587413
P/E ratio: 4.188547259333251
Shares outstanding: 9451242
Book value: 76823560.13986015
P/B ratio: 0.2968093048669665
Market cap (USD): 22801947.482517485
Debt to equity: 1.0033386465404592
Current ratio: 0.03666406517835859
Quick ratio: 0.03666406517835859
Effective tax rate (%): -188.2206675532624
Interest coverage ratio: 2.1592230578030285
COGS to revenue (%): 31.364022157069293
SG&A to revenue (%): 12.202347951433163
Free cash flow (dilution-adjusted): 2432427.272727273
Buyback yield (%): 0
Retained earnings: 72488632.86713287
Receivables turnover: 3.346694926064656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5038488689226128
FCF margin (%): 70.89942161374168
Rule of 40 score: 70.89942161374168
Financial ratios for IEI.V — quarterly report dated 2025-06-30
Total revenue: 3605967.1532846713
Gross profit: 2379264.2335766423
Operating income: 2084273.722627737
Net income: 1336554.7445255474
Capital expenditures: 0
Operating cash flow: 240915.32846715327
Depreciation & amortization: 32450.364963503645
Net tangible assets: 81386675.91240875
Owner earnings: 1369005.109489051
Return on net tangible assets (%): 1.682099795994154
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.5474452554744524
P/E ratio: 8.925412923183512
Shares outstanding: 9451242
Book value: 81386675.91240874
P/B ratio: 0.29582878673104784
Market cap (USD): 24076521.591240875
Debt to equity: 1.009227258688105
Current ratio: 0.1370264825303202
Quick ratio: 0.1370264825303202
Effective tax rate (%): 19.477749609169727
Interest coverage ratio: 2.2401716851330438
COGS to revenue (%): 34.01869366975866
SG&A to revenue (%): 7.2807137398978785
Free cash flow (dilution-adjusted): 240915.32846715327
Buyback yield (%): 0
Retained earnings: 76861897.81021897
Receivables turnover: 3.175268618852072
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.6046734987853182
FCF margin (%): 6.681018384976241
Revenue growth (%): 5.105294777994736
Rule of 40 score: 11.786313162970977
Financial ratios for IEI.V — quarterly report dated 2025-09-30
Total revenue: 3715639.568345324
Gross profit: 2536921.582733813
Operating income: 1981732.3741007196
Net income: -27707.91366906475
Capital expenditures: 0
Operating cash flow: 2858163.309352518
Depreciation & amortization: 31982.733812949642
Net tangible assets: 80231516.5467626
Owner earnings: 4274.820143884892
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.575539568345324
P/E ratio: 9.117497536632674
Shares outstanding: 9451242
Book value: 80231516.54676259
P/B ratio: 0.3033975772702681
Market cap (USD): 24342047.741007198
Debt to equity: 0.9859227622995496
Current ratio: 0.08235368024077047
Quick ratio: 0.08235368024077047
Effective tax rate (%): 109.26786423303214
Interest coverage ratio: 2.1045342167268193
COGS to revenue (%): 31.723151934686346
SG&A to revenue (%): 14.081195584133098
Free cash flow (dilution-adjusted): 2858163.309352518
Buyback yield (%): 0
Retained earnings: 75592274.8201439
Receivables turnover: 0.8264031963338805
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8561657021654465
FCF margin (%): 76.9225124444817
Revenue growth (%): 3.0414146995419085
Rule of 40 score: 79.9639271440236
Financial ratios for IEI.V — annual report dated 2025-09-30
Total revenue: 14330317.985611511
Gross profit: 9700743.165467627
Operating income: 8126893.525179856
Net income: 3500837.4100719425
Capital expenditures: 0
Operating cash flow: 7616088.489208634
Depreciation & amortization: 127931.654676259
Net tangible assets: 80231516.5467626
Owner earnings: 3628769.0647482015
Return on net tangible assets (%): 4.522872333633615
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.575539568345324
P/E ratio: 6.953207158657211
Shares outstanding: 9451242
Book value: 80231516.54676259
P/B ratio: 0.3033975772702681
Market cap (USD): 24342047.741007198
Debt to equity: 0.9859227622995496
Current ratio: 0.08235368024077047
Quick ratio: 0.08235368024077047
Effective tax rate (%): 3.0326290383775394
Interest coverage ratio: 2.2006574865312665
COGS to revenue (%): 32.30615555629856
SG&A to revenue (%): 10.08992254786878
Free cash flow (dilution-adjusted): 7436520.143884893
Buyback yield (%): 0
Retained earnings: 75592274.8201439
Receivables turnover: 3.1872361056441467
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.611956701991393
FCF margin (%): 51.89361569890912
Revenue growth (%): -0.9064877722812854
Rule of 40 score: 50.987127926627835
Financial ratios for IEI.V — quarterly report dated 2025-12-31
Total revenue: 3495202.919708029
Gross profit: 2342989.05109489
Operating income: 2016674.4525547444
Net income: 532291.9708029197
Capital expenditures: 0
Operating cash flow: 2196608.02919708
Depreciation & amortization: 32245.985401459853
Net tangible assets: 81797097.08029197
Owner earnings: 564537.9562043796
Return on net tangible assets (%): 0.6901686934564799
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.5985401459854014
P/E ratio: 7.669768213385989
Shares outstanding: 9451242
Book value: 81797097.08029196
P/B ratio: 0.3002482073699491
Market cap (USD): 24559431.766423356
Debt to equity: 0.9732153684214679
Current ratio: 0.06216132000942332
Quick ratio: 0.06216132000942332
Effective tax rate (%): 20.188070894321758
Interest coverage ratio: 2.1830188992317523
COGS to revenue (%): 32.965578682607315
SG&A to revenue (%): 8.413491859959052
Free cash flow (dilution-adjusted): 2196608.02919708
Buyback yield (%): 0
Retained earnings: 77090129.19708028
Receivables turnover: 0.8685945517070494
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0123005483970644
FCF margin (%): 62.84636628137669
Revenue growth (%): -5.932670394493126
Rule of 40 score: 56.91369588688356
Financial ratios for IRDM — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 303800000
Buffett classification: The Gruesome
Stock price: 38.67
Shares outstanding: 105960383
Market cap (USD): 4097488010.61
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRDM — annual report dated 2022-12-31
Total revenue: 721034000
Gross profit: 519885000
Operating income: 76679000
Net income: 8722000
Capital expenditures: 71267000
Operating cash flow: 344729000
Depreciation & amortization: 303484000
Net tangible assets: 1085978000
Owner earnings: 240939000
Return on net tangible assets (%): 22.186361049671355
Capex to operating income (%): 92.94200498180727
Buffett classification: The Gruesome
Stock price: 48.14
P/E ratio: 584.8352255927539
Shares outstanding: 105960383
Book value: 1128555000
P/B ratio: 4.519879702469087
Market cap (USD): 5100932837.62
Debt to equity: 1.3177780436044322
Current ratio: 2.16280893082916
Quick ratio: 1.8818593415597167
Effective tax rate (%): 2.7783063748810655
Interest coverage ratio: 1.1780638817618954
COGS to revenue (%): 27.897297492212576
R&D to revenue (%): 2.2492697986502717
SG&A to revenue (%): 17.128734567301958
Free cash flow (dilution-adjusted): 229730000
Buyback yield (%): 5.039450786416136
Retained earnings: -47744000
Inventory turnover: 5.057044448913918
Receivables turnover: 8.763920119601813
Capitalized R&D asset: 16218000
ROCI (R&D-adjusted, %): 3.0930280571805935
FCF margin (%): 31.861188238002647
Rule of 40 score: 31.861188238002647
Financial ratios for IRDM — annual report dated 2023-12-31
Total revenue: 790723000
Gross profit: 565603000
Operating income: 81628000
Net income: 15415000
Capital expenditures: 73487000
Operating cash flow: 314913000
Depreciation & amortization: 320000000
Net tangible assets: 847004000
Owner earnings: 261928000
Return on net tangible assets (%): 30.924057029246615
Capex to operating income (%): 90.02670652227177
Buffett classification: The Gruesome
Stock price: 38.94
P/E ratio: 267.6676817398638
Shares outstanding: 105960383
Book value: 888099000
P/B ratio: 4.645988019376218
Market cap (USD): 4126097314.02
Debt to equity: 1.669284618043709
Current ratio: 2.0606290952764645
Quick ratio: 1.3678717484835126
Interest coverage ratio: 0.9030944715501122
COGS to revenue (%): 28.47014694147002
R&D to revenue (%): 2.5633502503405112
SG&A to revenue (%): 18.174000250403743
Free cash flow (dilution-adjusted): 183971000
Buyback yield (%): 5.986746826369269
Retained earnings: -235397000
Inventory turnover: 2.470181598727163
Receivables turnover: 8.621523196859837
Capitalized R&D asset: 31135060
ROCI (R&D-adjusted, %): 3.5034046249183595
Rosenberg metric: 2.818966580342829
FCF margin (%): 23.266175386323656
Revenue growth (%): 9.66514755198784
Rule of 40 score: 32.931322938311496
Financial ratios for IRDM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.25
Shares outstanding: 105960383
Market cap (USD): 3099341202.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRDM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28
Shares outstanding: 105960383
Market cap (USD): 2966890724
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IRDM — annual report dated 2024-12-31
Total revenue: 830682000
Gross profit: 600115000
Operating income: 200384000
Net income: 112776000
Capital expenditures: 69890000
Operating cash flow: 375955000
Depreciation & amortization: 203127000
Net tangible assets: 387574000
Owner earnings: 246013000
Return on net tangible assets (%): 63.47510410915077
Capex to operating income (%): 34.87803417438518
Buffett classification: The Good
Stock price: 28
P/E ratio: 26.307820139036675
Shares outstanding: 105960383
Book value: 576637000
P/B ratio: 5.145161902548744
Market cap (USD): 2966890724
Debt to equity: 3.1057406999550845
Current ratio: 1.729939603106126
Quick ratio: 1.2495833678064463
Effective tax rate (%): 11.166472345697006
Interest coverage ratio: 2.19878420786973
COGS to revenue (%): 27.756349601893383
R&D to revenue (%): 3.42152592688899
SG&A to revenue (%): 20.24625548645571
Free cash flow (dilution-adjusted): 242608000
Buyback yield (%): 13.742501424194685
Retained earnings: -406092000
Inventory turnover: 2.836595598095543
Receivables turnover: 8.407457263443417
Capitalized R&D asset: 47354170
ROCI (R&D-adjusted, %): 8.125539655000281
Rosenberg metric: 1.7026987024520204
FCF margin (%): 29.20588143236521
Revenue growth (%): 5.053476375418446
Rule of 40 score: 34.25935780778366
Financial ratios for IRDM — quarterly report dated 2025-03-31
Total revenue: 214878000
Gross profit: 153224000
Operating income: 60388000
Net income: 30412000
Capital expenditures: 24546000
Operating cash flow: 61081000
Depreciation & amortization: 51667000
Net tangible assets: 329614000
Owner earnings: 57533000
Return on net tangible assets (%): 17.454659086082508
Capex to operating income (%): 40.647148440087435
Buffett classification: The Good
Stock price: 26.5
P/E ratio: 23.08258376216625
Shares outstanding: 105960383
Book value: 518445000
P/B ratio: 5.416100356836308
Market cap (USD): 2807950149.5
Debt to equity: 3.4853591027013473
Current ratio: 1.9854927889262652
Quick ratio: 1.3615512508216372
Effective tax rate (%): 15.778627403129153
Interest coverage ratio: 2.7670454545454546
COGS to revenue (%): 28.692560429639148
R&D to revenue (%): 2.520965385009168
SG&A to revenue (%): 16.638278464989437
Free cash flow (dilution-adjusted): 24787000
Buyback yield (%): 2.5099448440190337
Retained earnings: -425224000
Inventory turnover: 0.7641321187333457
Receivables turnover: 2.037820664801555
Capitalized R&D asset: 5417000
ROCI (R&D-adjusted, %): 2.5739312477033796
FCF margin (%): 11.535382868418358
Rule of 40 score: 11.535382868418358
Financial ratios for IRDM — quarterly report dated 2025-06-30
Total revenue: 216906000
Gross profit: 152001000
Operating income: 50258000
Net income: 21968000
Capital expenditures: 20710000
Operating cash flow: 129615000
Depreciation & amortization: 52837000
Net tangible assets: 285771000
Owner earnings: 54095000
Return on net tangible assets (%): 18.929492495739595
Capex to operating income (%): 41.2073699709499
Buffett classification: The Good
Stock price: 29.4
P/E ratio: 59.47375449026346
Shares outstanding: 105960383
Book value: 473615000
P/B ratio: 6.577568827423118
Market cap (USD): 3115235260.2
Debt to equity: 3.8199149097895972
Current ratio: 2.5086775033148356
Quick ratio: 1.748386779944016
Effective tax rate (%): 14.293223202553031
Interest coverage ratio: 2.208948663853727
COGS to revenue (%): 29.92310032917485
R&D to revenue (%): 1.972743953602021
SG&A to revenue (%): 20.57435017934036
Free cash flow (dilution-adjusted): 89816000
Buyback yield (%): 2.1056194643799957
Retained earnings: -446674000
Inventory turnover: 0.838468395147851
Receivables turnover: 2.6763649824171756
Capitalized R&D asset: 7908390
ROCI (R&D-adjusted, %): 2.0735958681247024
Rosenberg metric: -0.22577072180173527
FCF margin (%): 41.40779876997409
Revenue growth (%): 0.943791360679083
Rule of 40 score: 42.35159013065318
Financial ratios for IRDM — quarterly report dated 2025-09-30
Total revenue: 226935000
Gross profit: 163512000
Operating income: 70085000
Net income: 37127000
Capital expenditures: 21535000
Operating cash flow: 100782000
Depreciation & amortization: 52975000
Net tangible assets: 263640000
Owner earnings: 68567000
Return on net tangible assets (%): 26.00781368532848
Capex to operating income (%): 30.72697438824285
Buffett classification: The Good
Stock price: 17.16
P/E ratio: 20.31439074351727
Shares outstanding: 105960383
Book value: 450497000
P/B ratio: 4.036164885182365
Market cap (USD): 1818280172.28
Debt to equity: 4.017436298132951
Current ratio: 2.672781334443917
Quick ratio: 1.9348855678989627
Effective tax rate (%): 20.898796590339295
Interest coverage ratio: 3.1020670119063425
COGS to revenue (%): 27.947650208209403
R&D to revenue (%): 2.178597395730055
SG&A to revenue (%): 15.64677110185736
Free cash flow (dilution-adjusted): 66092000
Buyback yield (%): 2.7736099622514003
Retained earnings: -443419000
Inventory turnover: 0.8324648562090645
Receivables turnover: 2.401581052765255
Capitalized R&D asset: 9598540
ROCI (R&D-adjusted, %): 2.8511223018680942
Rosenberg metric: 2.6901145127366206
FCF margin (%): 29.12375790424571
Revenue growth (%): 4.623661862742386
Rule of 40 score: 33.747419766988095
Financial ratios for IRDM — annual report dated 2025-12-31
Total revenue: 871659000
Gross profit: 623656000
Operating income: 235980000
Net income: 114372000
Capital expenditures: 100280000
Operating cash flow: 400073000
Depreciation & amortization: 210207000
Net tangible assets: 276730000
Owner earnings: 224299000
Return on net tangible assets (%): 81.0533733241788
Capex to operating income (%): 42.49512670565302
Buffett classification: The Good
Stock price: 17.22
P/E ratio: 15.9535357890043
Shares outstanding: 105960383
Book value: 462600000
P/B ratio: 3.944309976783398
Market cap (USD): 1824637795.26
Debt to equity: 3.8057198443579767
Current ratio: 2.476072356049073
Quick ratio: 1.8155189397331424
Effective tax rate (%): 19.071492200285885
Interest coverage ratio: 2.6739337352128
COGS to revenue (%): 28.451837243692772
R&D to revenue (%): 2.2667120972765726
SG&A to revenue (%): 18.09319929008936
Free cash flow (dilution-adjusted): 248214000
Buyback yield (%): 10.21983653327911
Retained earnings: -418554000
Inventory turnover: 3.362114310503769
Receivables turnover: 9.295514652561533
Capitalized R&D asset: 45489510
ROCI (R&D-adjusted, %): 9.449812257594612
Rosenberg metric: 0.8282668355499261
FCF margin (%): 28.476043957556797
Revenue growth (%): 4.932934624802271
Rule of 40 score: 33.40897858235907
Financial ratios for IRDM — quarterly report dated 2025-12-31
Total revenue: 212940000
Gross profit: 154919000
Operating income: 55249000
Net income: 24865000
Capital expenditures: 33489000
Operating cash flow: 108595000
Depreciation & amortization: 52728000
Net tangible assets: 276730000
Owner earnings: 44104000
Return on net tangible assets (%): 15.937556462978355
Capex to operating income (%): 60.61467175876486
Buffett classification: The Good
Stock price: 17.22
P/E ratio: 15.9535357890043
Shares outstanding: 105960383
Book value: 462600000
P/B ratio: 3.944309976783398
Market cap (USD): 1824637795.26
Debt to equity: 3.8057198443579767
Current ratio: 2.476072356049073
Quick ratio: 1.8155189397331424
Effective tax rate (%): 23.89412292507851
Interest coverage ratio: 2.620547360432576
COGS to revenue (%): 27.247581478350707
R&D to revenue (%): 2.4034939419554804
SG&A to revenue (%): 19.641213487367335
Free cash flow (dilution-adjusted): 67519000
Buyback yield (%): 0.0016441619305449704
Retained earnings: -418554000
Inventory turnover: 0.7865761075863565
Receivables turnover: 2.2708271125709167
Capitalized R&D asset: 9842550
ROCI (R&D-adjusted, %): 2.28828786661362
Rosenberg metric: -1.7380663430420713
FCF margin (%): 31.707992861839017
Revenue growth (%): -6.166964108665477
Rule of 40 score: 25.541028753173542
Financial ratios for JSWSTEEL.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.182645391006199
Shares outstanding: 2440826972
Market cap (USD): 22413248544.679417
Buyback yield (%): 0.3477295654064422
Retained earnings: 5619807464.064355
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JSWSTEEL.NS — annual report dated 2023-03-31
Total revenue: 19932521315.46894
Gross profit: 6757612667.478685
Operating income: 1602801461.6321561
Net income: 504750304.5066992
Capital expenditures: 1796467722.2898905
Operating cash flow: 2840803897.685749
Depreciation & amortization: 910353227.771011
Net tangible assets: 7732277710.109623
Owner earnings: -381364190.0121803
Return on net tangible assets (%): -4.932106738918119
Capex to operating income (%): 112.08298502925753
Buffett classification: The Gruesome
Stock price: 8.21181485992692
P/E ratio: 39.70996950416699
Shares outstanding: 2440826972
Book value: 8165529841.656517
P/B ratio: 2.4546624147924043
Market cap (USD): 20043619199.180027
Debt to equity: 1.590193767806799
Current ratio: 0.9740863027600303
Quick ratio: 0.5004788245215328
Effective tax rate (%): 26.808134394341288
Interest coverage ratio: 2.102076677316294
COGS to revenue (%): 66.09755203304695
SG&A to revenue (%): 5.139141806093642
Free cash flow (dilution-adjusted): 1013398294.7624849
Buyback yield (%): 0
Retained earnings: 5192082825.822168
Inventory turnover: 3.264403199034254
Receivables turnover: 22.93888421642837
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.325018601849557
FCF margin (%): 5.084145044791807
Rule of 40 score: 5.084145044791807